Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Paracetamol with Synflorix, Infanrix Hexa, and Rotarix
NCT00370318Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection (2 arms), sponsored by GSK. Primary endpoint: Occurrence of fever > or = to 38°C (rectal temperature). Started Sep 2006; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00370318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370318.